Hims & Hers Health, Inc. (HIMS) insider details RSU vesting, 164,369 shares

Rhea-AI Filing Summary

Hims & Hers Health, Inc. reported insider equity activity by its chief executive officer, who is also a director and 10% owner, on December 15, 2025. The filing shows the acquisition of 164,369 shares of Class A Common Stock through the settlement of restricted stock units.

On the same date, 90,660 shares of Class A Common Stock were disposed of at $36.25 per share, as the issuer withheld these shares to cover tax withholding obligations related to the RSU vesting. Following these transactions, the reporting person held 878,732 Class A shares directly, in addition to substantial indirect holdings through multiple family trusts.

The RSU awards each convert into one share of Class A Common Stock and are subject to four-year, service-based vesting in substantially equal quarterly installments on Company Quarterly Vesting Dates. Depending on the grant, these quarterly vesting schedules began on June 15, 2022, June 15, 2023, June 15, 2024 and June 15, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dudum Andrew

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/15/2025		M		164,369	A	(1)	969,392	D
Class A Common Stock	12/15/2025		F		90,660(2)	D	$36.25	878,732	D
Class A Common Stock								384,731	I	Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
Class A Common Stock								508,030	I	Held by Trustee of AD 2022 GRAT
Class A Common Stock								186,723	I	Held by Trustee of AD 2025 GRAT dated 5-27-2025
Class A Common Stock								47,524	I	Held by Trustee of Dudum Family Community Property Trust
Class A Common Stock								791,117	I	Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
Class A Common Stock								1,080,972	I	Held by Trustee of Dudum Legacy 2021 Trust
Class A Common Stock								2,214,769	I	Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021
Class A Common Stock								3,004,071	I	Held by Trustee of Dudum Family 2021 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	12/15/2025		M			35,242	(3)	(3)	Class A Common Stock	35,242	$0	35,242	D
Restricted Stock Unit	(1)	12/15/2025		M			35,446	(4)	(4)	Class A Common Stock	35,446	$0	177,233	D
Restricted Stock Unit	(1)	12/15/2025		M			74,530	(5)	(5)	Class A Common Stock	74,530	$0	670,769	D
Restricted Stock Unit	(1)	12/15/2025		M			19,151	(6)	(6)	Class A Common Stock	19,151	$0	248,955	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.

4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.

5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.

6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hims & Hers Health (HIMS) report here?

The report shows that on December 15, 2025, the chief executive officer, who is also a director and 10% owner, acquired 164,369 shares of Hims & Hers Class A Common Stock through the settlement of restricted stock units and had shares withheld to cover taxes.

How many Hims & Hers Class A shares does the CEO own directly and indirectly after this transaction?

After the reported transactions, the reporting person directly owned 878,732 Class A shares. Indirect holdings included, among others, 384,731 shares held by the trustee of the Andrew Dudum 2015 Trust, 508,030 shares held by the trustee of the AD 2022 GRAT, 1,080,972 shares held by the trustee of the Dudum Legacy 2021 Trust, and 3,004,071 shares held by the trustee of the Dudum Family 2021 Trust.

Why were 90,660 Hims & Hers shares disposed of at $36.25?

The 90,660 shares of Class A Common Stock were withheld by the issuer at $36.25 per share to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units, as noted in the explanatory footnote.

What are the vesting terms of the Hims & Hers RSUs in this report?

The restricted stock units represent a contingent right to receive one Class A share per RSU. They are subject to service-based vesting over four-year periods, vesting in substantially equal quarterly installments on Company Quarterly Vesting Dates of March 15, June 15, September 15 and December 15, with first vesting dates on June 15, 2022, June 15, 2023, June 15, 2024 and June 15, 2025, depending on the grant.

How many restricted stock units remain outstanding for the Hims & Hers CEO?

After the reported transactions, remaining RSU balances included 35,242, 177,233, 670,769 and 248,955 restricted stock units, each RSU representing the right to receive one share of Class A Common Stock upon vesting and settlement.

What roles does the reporting person hold at Hims & Hers Health, Inc.?

The reporting person is identified as a Director, a 10% Owner, and an Officer of Hims & Hers Health, Inc., serving as Chief Executive Officer.